Growth Metrics

LifeStance Health (LFST) Depreciation & Amortization (CF) (2020 - 2025)

LifeStance Health (LFST) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $13.4 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 8.43% to $13.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.8 million through Dec 2025, down 22.83% year-over-year, with the annual reading at $54.8 million for FY2025, 22.83% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $13.4 million at LifeStance Health, down from $13.6 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $22.6 million in Q1 2024, with the low at $12.2 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $16.5 million, with a median of $15.5 million recorded in 2021.
  • The sharpest move saw Depreciation & Amortization (CF) surged 135.16% in 2021, then crashed 39.04% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $15.4 million in 2021, then rose by 22.99% to $18.9 million in 2022, then increased by 17.63% to $22.2 million in 2023, then crashed by 33.96% to $14.7 million in 2024, then fell by 8.43% to $13.4 million in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $13.4 million, $13.6 million, and $14.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.